OpportunityTitle: Developmental Pharmacology (R21)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:   Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and participating Institutes within the National Institutes of Health (NIH) invite grant applications for research related to developmental pharmacology. To encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways activity acrossdevelopmental periods from fetal life to adolescence.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV &lt;br/&gt;